State Street’s Tobira Therapeutics, Inc. Common Stock TBRA Stock Holding History

State Street’s Portfolio TBRA Stock Details TBRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-125,077	Closed	-$4.97M	–	3731
2016 Q3	$4.97M	Buy	125,077 +15,550	+14%	+$173K	﹤0.01%	2568
2016 Q2	$1.38M	Buy	109,527 +66,652	+155%	+$621K	﹤0.01%	3176
2016 Q1	$351K	Buy	42,875 +27,794	+184%	+$210K	﹤0.01%	3409
2015 Q4	$151K	Sell	15,081 -525	-3%	-$5.45K	﹤0.01%	3520
2015 Q3	$150K	Sell	15,606 -9,536	-38%	-$134K	﹤0.01%	3497
2015 Q2	$435K	Buy	25,142 +15,807	+169%	+$231K	﹤0.01%	3384
2015 Q1	$102K	Buy	9,335 +2,600	+39%	+$27.9K	﹤0.01%	3541
2014 Q4	$55K	Buy	6,735 +77	+1%	+$663	﹤0.01%	3581
2014 Q3	$67K	Buy	6,658 +2,034	+44%	+$40.2K	﹤0.01%	3545
2014 Q2	$283K	Buy	+4,624	New	+$281K	﹤0.01%	3387

State Street's TBRA Position: Q4 2016 in Review

State Street sold out of Tobira Therapeutics, Inc. Common Stock (TBRA) in Q4 2016, closing a stake of 125,077 shares — an estimated $4.97M sold.

State Street first reported a position in TBRA in Q2 2014 and held it in 10 quarters. The position peaked at $4.97M in Q3 2016. 0 funds tracked by Wall St. Rank hold TBRA as of Q4 2016.

State Street reported no remaining Tobira Therapeutics, Inc. Common Stock position as of Q4 2016 after selling out during the quarter.
State Street sold 125,077 Tobira Therapeutics, Inc. Common Stock shares in Q4 2016, an estimated $4.97M.
State Street first reported a position in Tobira Therapeutics, Inc. Common Stock in Q2 2014 and held it in 10 quarters.
State Street's Tobira Therapeutics, Inc. Common Stock position peaked at $4.97M in Q3 2016.
0 funds tracked by Wall St. Rank held Tobira Therapeutics, Inc. Common Stock as of Q4 2016.

Based on State Street's 13F filing for Q4 2016, filed 9 Feb 2017.